The earnings call reflected a strategic shift with positive momentum from the AYON system launch and restructuring benefits, countered by revenue declines in OEM and overall sales. The updated revenue guidance indicates optimism for future growth.

Company Guidance

During the second quarter 2025 earnings call, Apyx Medical announced a strategic shift in focus, highlighted by the appointment of two seasoned sales leaders to drive growth in both domestic and international markets. The company reported a total revenue of $11.4 million, down 6% from the previous year, with Advanced Energy products generating $9.7 million. Despite a dip in sales of OEM products and single-use handpieces, Apyx experienced strong presales for its new AYON system, which combines multiple body contouring technologies. The company revised its full-year 2025 revenue guidance upward to $50-52 million, with anticipated Advanced Energy revenue between $42-44 million. Operational efficiency improvements contributed to a reduced net loss of $3.8 million and an adjusted EBITDA loss of $2 million. Apyx also highlighted the positive market reception of its Renuvion product and its expansion into China through a partnership with GlamMoon Medical Technology, aiming to capitalize on a growing aesthetic market influenced by the increasing use of GLP-1 drugs.

Successful Appointment of Senior Sales Leaders

John Featherstone and Simon Davies were appointed as senior sales leaders for North America and Europe/Asia, respectively, bringing extensive experience in the aesthetics industry.

AYON System Pre-Sales Exceed Expectations

Early results from AYON presales have exceeded expectations, leading to an update in revenue targets for 2025.

Cost Reduction and Restructuring Benefits

Significant improvements from cost reduction and restructuring initiatives implemented in November 2024 have resulted in a leaner operating structure and reduced cash burn.

Launch of Renuvion in China

Renuvion launched in China with a distribution agreement with GlamMoon Medical Technology, generating strong interest from surgeons and patients.

Updated Revenue Guidance for 2025

Total revenue guidance increased to $50 million to $52 million from previous guidance of $47.6 million to $49 million, driven by the AYON system launch.

Apyx Medical (APYX) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

APYX Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 06, 2025	2025 (Q3)	-0.10 / -	-0.14	―	―	―
Aug 07, 2025	2025 (Q2)	-0.09 / -0.09	-0.19	52.63% (+0.10)	―
May 08, 2025	2025 (Q1)	-0.12 / -0.10	-0.22	54.55% (+0.12)	―
Mar 13, 2025	2024 (Q4)	-0.16 / -0.12	-0.28	57.14% (+0.16)	―
Nov 08, 2024	2024 (Q3)	-0.18 / -0.14	-0.13	-7.69% (-0.01)	―
Aug 08, 2024	2024 (Q2)	-0.20 / -0.19	-0.03	-533.33% (-0.16)	―
May 09, 2024	2024 (Q1)	-0.22 / -0.22	-0.1	-120.00% (-0.12)	―
Mar 21, 2024	2023 (Q4)	-0.18 / -0.28	-0.17	-64.71% (-0.11)	―
Nov 09, 2023	2023 (Q3)	-0.11 / -0.13	-0.17	23.53% (+0.04)	―
Aug 10, 2023	2023 (Q2)	-0.07 / -0.03	-0.16	81.25% (+0.13)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

APYX Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 07, 2025	$1.96	$2.18	+11.22%
May 08, 2025	$1.25	$1.18	-5.60%
Mar 13, 2025	$1.07	$1.04	-2.80%
Nov 08, 2024	$1.22	$1.52	+24.59%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Apyx Medical Corporation (APYX) report earnings?

Apyx Medical Corporation (APYX) is schdueled to report earning on Nov 06, 2025, After Close (Confirmed).

What is Apyx Medical Corporation (APYX) earnings time?

Apyx Medical Corporation (APYX) earnings time is at Nov 06, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is APYX EPS forecast?

APYX EPS forecast for the fiscal quarter 2025 (Q3) is -0.1.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing